The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates

doi:10.1016/j.jinf.2020.06.060

Comment

. 2020 Sep;81(3):e44-e47.

doi: 10.1016/j.jinf.2020.06.060. Epub 2020 Jun 25.

The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates

Xuan Liang¹, Li Shi¹, Ying Wang¹, Wenwei Xiao¹, Guangcai Duan¹, Haiyan Yang², Yadong Wang³

Affiliations

¹ Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.
² Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China. Electronic address: yhy@zzu.edu.cn.
³ Department of Toxicology, Henan Center for Disease Control and Prevention, No. 105 of South Nongye Road, Zhengzhou 450016, China. Electronic address: wangyd76@163.com.

PMID: 32593655
PMCID: PMC7315979
DOI: 10.1016/j.jinf.2020.06.060

Comment

The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates

Xuan Liang et al. J Infect. 2020 Sep.

. 2020 Sep;81(3):e44-e47.

doi: 10.1016/j.jinf.2020.06.060. Epub 2020 Jun 25.

Authors

Xuan Liang¹, Li Shi¹, Ying Wang¹, Wenwei Xiao¹, Guangcai Duan¹, Haiyan Yang², Yadong Wang³

Affiliations

¹ Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.
² Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China. Electronic address: yhy@zzu.edu.cn.
³ Department of Toxicology, Henan Center for Disease Control and Prevention, No. 105 of South Nongye Road, Zhengzhou 450016, China. Electronic address: wangyd76@163.com.

PMID: 32593655
PMCID: PMC7315979
DOI: 10.1016/j.jinf.2020.06.060

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest All authors report that they have no potential conflicts of interest.

Figures

Fig 1 — **Fig. 1.**
The pooled effects and their 95% confidence interval (CI) of the relationship between hypertension and adverse outcomes in patients with COVID-19 (A). Sensitivity analysis of the relationship between hypertension and adverse outcomes in patients with COVID-19 (B).

See this image and copyright information in PMC

Comment on

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Zheng Z, et al. J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23. J Infect. 2020. PMID: 32335169 Free PMC article.

Cited by

Comparison of Clinical Characteristics and Outcome of Critically Ill Patients Admitted to Tertiary Care Intensive Care Units in India during the Peak Months of First and Second Waves of COVID-19 Pandemic: A Retrospective Analysis.
Kerai S, Singh R, Dutta S, Mahajan A, Agarwal M. Kerai S, et al. Indian J Crit Care Med. 2021 Dec;25(12):1349-1356. doi: 10.5005/jp-journals-10071-24046. Indian J Crit Care Med. 2021. PMID: 35027793 Free PMC article.
Examining and investigating the impact of demographic characteristics and chronic diseases on mortality of COVID-19: Retrospective study.
Al Mutair A, Al Mutairi A, Alhumaid S, Maaz Abdullah S, Zia Zaidi AR, Rabaan AA, Al-Omari A. Al Mutair A, et al. PLoS One. 2021 Sep 10;16(9):e0257131. doi: 10.1371/journal.pone.0257131. eCollection 2021. PLoS One. 2021. PMID: 34506551 Free PMC article.
Health systems interventions for hypertension management and associated outcomes in Sub-Saharan Africa: A systematic review.
Byiringiro S, Ogungbe O, Commodore-Mensah Y, Adeleye K, Sarfo FS, Himmelfarb CR. Byiringiro S, et al. PLOS Glob Public Health. 2023 Jun 8;3(6):e0001794. doi: 10.1371/journal.pgph.0001794. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37289741 Free PMC article.
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies.
Elemam NM, Maghazachi AA, Hannawi S. Elemam NM, et al. Curr Med Res Opin. 2021 Jun;37(6):929-938. doi: 10.1080/03007995.2021.1906637. Epub 2021 Apr 8. Curr Med Res Opin. 2021. PMID: 33754931 Free PMC article. Review.
Association Between the LZTFL1 rs11385942 Polymorphism and COVID-19 Severity in Colombian Population.
Angulo-Aguado M, Corredor-Orlandelli D, Carrillo-Martínez JC, Gonzalez-Cornejo M, Pineda-Mateus E, Rojas C, Triana-Fonseca P, Contreras Bravo NC, Morel A, Parra Abaunza K, Restrepo CM, Fonseca-Mendoza DJ, Ortega-Recalde O. Angulo-Aguado M, et al. Front Med (Lausanne). 2022 Jun 20;9:910098. doi: 10.3389/fmed.2022.910098. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35795626 Free PMC article.

See all "Cited by" articles

References

1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Feb 7. - DOI - PMC - PubMed
1. Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis IJID. 2020;94:91–95. doi: 10.1016/j.ijid.2020.03.017. official publication of the International Society for Infectious DiseasesMay. - DOI - PMC - PubMed
1. Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020 doi: 10.1016/j.jinf.2020.04.021. Apr 23. - DOI - PMC - PubMed
1. Chen F., Sun W., Sun S., Li Z., Wang Z., Yu L. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clin Transl Med. 2020 doi: 10.1002/ctm2.40. Jun 4. - DOI - PMC - PubMed
1. Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/s0140-6736(20)31189-2. Jun 6. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Feb 7. - DOI - PMC - PubMed

[2] Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Feb 7. - DOI - PMC - PubMed

[3] Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis IJID. 2020;94:91–95. doi: 10.1016/j.ijid.2020.03.017. official publication of the International Society for Infectious DiseasesMay. - DOI - PMC - PubMed

[4] Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis IJID. 2020;94:91–95. doi: 10.1016/j.ijid.2020.03.017. official publication of the International Society for Infectious DiseasesMay. - DOI - PMC - PubMed

[5] Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020 doi: 10.1016/j.jinf.2020.04.021. Apr 23. - DOI - PMC - PubMed

[6] Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020 doi: 10.1016/j.jinf.2020.04.021. Apr 23. - DOI - PMC - PubMed

[7] Chen F., Sun W., Sun S., Li Z., Wang Z., Yu L. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clin Transl Med. 2020 doi: 10.1002/ctm2.40. Jun 4. - DOI - PMC - PubMed

[8] Chen F., Sun W., Sun S., Li Z., Wang Z., Yu L. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clin Transl Med. 2020 doi: 10.1002/ctm2.40. Jun 4. - DOI - PMC - PubMed

[9] Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/s0140-6736(20)31189-2. Jun 6. - DOI - PMC - PubMed

[10] Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/s0140-6736(20)31189-2. Jun 6. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates

Affiliations

The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates

Authors

Affiliations

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical